A case of levocetirizine-induced liver injury
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Levocetirizine is a second-generation nonsedative antihistaminic agent that has been demonstrated to be safe and effective for treating allergic disease. There was only one case report of levocetirizine-induced liver toxicity, but a liver biopsy was not performed. In this article, we present the first case of levocetirizine-induced liver injury with histologic findings. A 48-year-old man was hospitalized with jaundice and generalized pruritus that had developed after 2 months of therapy with levocetirizine for prurigo nodularis. Laboratory findings revealed acute hepatitis with cholestasis. A liver biopsy demonstrated portal inflammation and hepatitis with apoptotic hepatocytes. The patient fully recovered 3 weeks after withdrawing levocetirizine. Although levocetirizine is safe and effective, physicians should be aware of its potential hepatotoxicity. (Clin Mol Hepatol 2016;22:495-498)
Abstract
Levocetirizine is a second-generation nonsedative antihistaminic agent that has been demonstrated to be safe and effective for treating allergic disease. There was only one case report of levocetirizine-induced liver toxicity, but a liver biopsy was not performed. In this article, we present the first case of levocetirizine-induced liver injury with histologic findings. A 48-year-old man was hospitalized with jaundice and generalized pruritus that had developed after 2 months of therapy with levocetirizine for prurigo nodularis. Laboratory findings revealed acute hepatitis with cholestasis. A liver biopsy demonstrated portal inflammation and hepatitis with apoptotic hepatocytes. The patient fully recovered 3 weeks after withdrawing levocetirizine. Although levocetirizine is safe and effective, physicians should be aware of its potential hepatotoxicity. (Clin Mol Hepatol 2016;22:495-498)
참고문헌 (13)
- Gillard M, "H1 antagonists: receptor affinity versus selectivity", Inflamm Res, 52(Suppl 1), pp.S49~S50 (2003)
- Grant JA, "A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects", Ann Allergy Asthma Immunol, 88, pp.190~197 (2002)
- "UCB Pharma Inc, Smyrna, Ga", 2008
- Maiti R, "Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety", Arch Otolaryngol Head Neck Surg, 136, pp.796~800 (2010)
- Ekiz F, "Levocetirizineinduced hepatotoxicity in a patient with chronic urticaria", Ann Hepatol, 10, pp.237~238 (2011)
- Lee WM, "Acute liver failure in the United States", Semin Liver Dis, 23, pp.217~226 (2003)
- Lewis JH, "Drug-induced liver disease", Med Clin Nor th Am, 84, pp.1275~1311 (2000)
- Suk KT, "A prospective nationwide study of drug-induced liver injury in Korea", Am J Gastroenterol, 107, pp.1380~1387 (2012)
- 김승현, "Update on Advances in Research on Idiosyncratic Drug-Induced Liver Injury", Allergy, Asthma & Immunology Research, 8(1), pp.3~11 (2016), 대한천식알레르기학회
- Holgate S, "A treatment for allergic rhinitis: a view on the role of levocetirizine", Curr Med Res Opin, 21, pp.1099~1106 (2005)
- Hair PI, "Levocetirizine: a review of its use in the management of allergic rhinitis and skin allergies", Drugs, 66, pp.973~996 (2006)
- Segall N, "Efficacy and safety of levocetirizine in improving symptoms and health-related quality of life in US adults with seasonal allergic rhinitis: a randomized, placebocontrolled study", Ann Allergy Asthma Immunol, 104, pp.259~267 (2010)
- Suk KT, "Drug-induced liver injury: present and future", Clin Mol Hepatol, 18, pp.249~257 (2012)